| Designed protein logic to target cells with precise combinations of surface antigens MJ Lajoie, SE Boyken, AI Salter, J Bruffey, A Rajan, RA Langan, ... Science 369 (6511), 1637-1643, 2020 | 177 | 2020 |
| Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets ZR Crook, GP Sevilla, D Friend, MY Brusniak, AD Bandaranayake, ... Nature communications 8 (1), 2244, 2017 | 83 | 2017 |
| Development of spirulina for the manufacture and oral delivery of protein therapeutics BW Jester, H Zhao, M Gewe, T Adame, L Perruzza, DT Bolick, J Agosti, ... Nature biotechnology 40 (6), 956-964, 2022 | 80 | 2022 |
| Screening, large-scale production and structure-based classification of cystine-dense peptides CE Correnti, MM Gewe, C Mehlin, AD Bandaranayake, WA Johnsen, ... Nature structural & molecular biology 25 (3), 270-278, 2018 | 61 | 2018 |
| A potent peptide-steroid conjugate accumulates in cartilage and reverses arthritis without evidence of systemic corticosteroid exposure ML Cook Sangar, EJ Girard, G Hopping, C Yin, F Pakiam, MY Brusniak, ... Science translational medicine 12 (533), eaay1041, 2020 | 39 | 2020 |
| Ontogeny of recognition specificity and functionality for the broadly neutralizing anti-HIV antibody 4E10 KAK Finton, D Friend, J Jaffe, M Gewe, MA Holmes, HB Larman, A Stuart, ... PLoS pathogens 10 (9), e1004403, 2014 | 31 | 2014 |
| Control of tumor initiation by NKG2D naturally expressed on ovarian cancer cells X Cai, A Caballero-Benitez, MM Gewe, IC Jenkins, CW Drescher, ... Neoplasia 19 (6), 471-482, 2017 | 28 | 2017 |
| Detection and activation of HIV broadly neutralizing antibody precursor B cells using anti-idiotypes T Bancroft, BL DeBuysscher, C Weidle, A Schwartz, A Wall, MD Gray, ... Journal of Experimental Medicine 216 (10), 2331-2347, 2019 | 24 | 2019 |
| Anti-CD28 antibody-initiated cytokine storm in canines SL Rosinski, R Storb, RK Strong, GE Sale, DM Stone, MM Gewe, ... Transplantation direct 1 (2), 1-11, 2015 | 14 | 2015 |
| Design of functionalised circular tandem repeat proteins with longer repeat topologies and enhanced subunit contact surfaces JP Hallinan, LA Doyle, BW Shen, MM Gewe, B Takushi, MA Kennedy, ... Communications Biology 4 (1), 1240, 2021 | 13 | 2021 |
| Expression and manufacturing of protein therapeutics in spirulina B Jester, H Zhao, M Gewe, T Adame, L Perruzza, D Bolick, J Agosti, ... BioRxiv, 2021.01. 25.427910, 2021 | 12 | 2021 |
| Ex silico engineering of cystine-dense peptides yielding a potent bispecific T cell engager ZR Crook, EJ Girard, GP Sevilla, MY Brusniak, PB Rupert, DJ Friend, ... Science translational medicine 14 (645), eabn0402, 2022 | 5 | 2022 |
| Using synthetic activity to design ultra-potent antibody cocktails H Zhao, M Dodds, M Tasch, M Gewe, A Martinez, M Hutton, K Keeney, ... | 4 | 2021 |
| Arthrospira platensis non-parenteral therapeutic delivery platform J Roberts, M Tasch, M Gewe, B Jester, T Saveria US Patent App. 17/246,837, 2021 | 2 | 2021 |
| Survival and growth performance of some eucalyptus species/Provenances in elimination trial at aman, south-western Ethiopia. M Mihretu, B Gizachew, M Mulugeta Ethiopian Journal of Natural Resources., 2002 | 1 | 2002 |
| Constructs comprising single domain vhh antibodies against sars cov-2 JM Roberts, B Jester, MM Gewe, NY Khuong US Patent App. 18/268,844, 2024 | | 2024 |
| Advances in cystine-dense peptide (CDP) screening and therapeutic applications ZR Crook, EJ Girard, GP Sevilla, MY Brusniak, PB Rupert, DJ Friend, ... Cancer Research 82 (12_Supplement), 1043-1043, 2022 | | 2022 |
| NKG2D decoys M Gewe, K Roland, M Prlic, P Rupert, T Spies, V Spies US Patent 10,815,290, 2020 | | 2020 |
| Stable peptides and methods of use thereof EJ Girard, C Correnti, J Olson, NW Nairn, MM Gewe, C Mehlin, Z Crook, ... US Patent App. 16/330,069, 2019 | | 2019 |
| Peptides and methods of use thereof J Olson, T Sottero, E Girard, A Mhyre, C Correnti, C Mehlin, MM Gewe, ... US Patent App. 16/326,154, 2019 | | 2019 |
